Keros Therapeutics Inc (KROS)

Change in Working Capital

$1.86M

Quarterly · Period ending: · USD

KROS logo

KROS Change in Working Capital

Latest reported$1.86M
KROS Quarterly Change in Working Capital (-$39.00K → $1.86M)
High-resolution chart · PNG

KROS change in working capital history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc Change in Working Capital — Quarterly (USD)
Period endingChange in Working Capital (USD)
1,858,000
12,941,000
-12,159,000
5,539,000
-8,420,000
2,929,000
-10,086,000
12,762,000
-3,981,000
-10,132,000
6,878,000
-3,804,000
-913,000
-4,811,000
3,080,000
-6,195,000
-632,000
18,055,000
-16,957,000
3,258,000
-5,078,000
2,707,000
990,000
-365,000
-468,000
2,118,000
-3,691,000
-68,000
-2,926,000
-39,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.